Concomitant infusional paclitaxel and fluorouracil, oral hydroxyurea, and hyperfractionated radiation for locally advanced squamous head and neck cancer

Journal of Clinical Oncology

Volumn 19, Issue 7, 2001, Pages 1961-1969

  Kies, M S ^a   Haraf, D J ^a   Rosen, F ^a   Stenson, K ^a   List, M ^a   Brockstein, B ^a   Chung, T ^a   Mittal, B B ^a   Pelzer, H ^a   Portugal, L ^a   Rademaker, A ^a   Weichselbaum, R ^a   Vokes, E E ^a  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; HYDROXYUREA; PACLITAXEL; TAXANE DERIVATIVE;

ADULT; ADVANCED CANCER; AGED; ANEMIA; ARTICLE; CANCER GROWTH; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL TRIAL; DISEASE CONTROL; DRUG TOLERABILITY; FEMALE; FOLLOW UP; FRACTIONATION; HEAD AND NECK CANCER; HIGH RISK PATIENT; HUMAN; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; ORGAN PRESERVATION; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RADIATION DOSE; SQUAMOUS CELL CARCINOMA; XEROSTOMIA;

EID: 0035300759     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2001.19.7.1961     Document Type: Article

References (27)

1. Radiotherapy and concurrent chemotherapy: A strategy that improves locoregional control and survival in oropharyngeal cancer
2. Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma
3. Five-year update of a randomized trial of alternating radiotherapy and chemotherapy compared with radiotherapy alone in treatment of unresectable squamous cell carcinoma of the head and neck
4. Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: A randomized multicenter study
5. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer
6. A phase III comparison of standard radiation therapy (RT) versus RT plus concurrent cisplatin (DDP) versus split-course RT plus concurrent DDP and 5-fluorouracil (5-FU) in patients with unresectable squamous cell head and neck cancer (SCHNC): An intergroup study
7. Meta-analyses in head and neck squamous cell carcinoma: What is the role of chemotherapy?
8. Induction chemotherapy plus radiation in patients with advanced laryngeal cancer
9. Larynx preservation in pyriform sinus cancer: Preliminary results of a European Organization for Research and Treatment of Cancer phase III trial - EORTC Head and Neck Cancer Cooperative Group
10. Cisplatin, fluorouracil, and leucovorin augmented by interferon alfa-2b in head and neck cancer: A clinical and pharmacologic analysis
11. Induction chemotherapy followed by concomitant chemoradiotherapy for advanced head and neck cancer: Impact on the natural history of the disease
12. Pharmacodynamics of fluorouracil-based induction chemotherapy in advanced head and neck cancer
13. Induction chemotherapy followed by concurrent chemoradiation for advanced head and neck cancer: Improved disease control and survival
14. Concomitant chemoradiotherapy as primary therapy for locoregionally advanced head and neck cancer
15. Phase I study of concomitant chemoradiotherapy with paclitaxel, fluorouracil, and hydroxyurea with granulocyte colony-stimulating factor support for patients with poor-prognosis cancer of the head and neck
16. The functional Assessment of cancer therapy scale: Development and validation of the general measure
17. A performance status scale for head and neck cancer patients
18. The performance status scale for head and neck cancer patients and the functional assessment of cancer therapy-head and neck scale: A study of utility and validity
19. The head and neck radiotherapy questionnaire: A morbidity/quality-of-life instrument for clinical trials of radiation therapy in locally advanced head and neck cancer
20. Performance and quality of life outcome in patients completing concomitant chemoradiotherapy protocols for head and neck cancer
21. Quality of life and performance in advanced head and neck cancer patients on concomitant chemoradiotherapy: A prospective examination
22. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: First report of RTOG 9003
23. Concomitant chemoradiotherapy (CRT) with paclitaxel (T), 5-fluorouracil (F), Hydroxyurea (H) and twice daily (BID) radiotherapy (RT) for locoregionally advanced head and neck cancer (HNC)
24. Patterns of relapse in locally advanced head and neck cancer patients who achieved complete remission after combined modality therapy
25. Randomized study of preoperative versus postoperative radiation therapy in advanced head and neck carcinoma: Long-term follow-up of RTOG study 73-03
26. Combined therapy for squamous head and neck cancer